疗效和安全性-话题@MedSci

#疗效和安全性#

431篇内容 | 2559人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1720863, encodeId=84791e20863b5, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Rheumatol：皮下阿巴西普治疗类风湿性关节炎的长期疗效和安全性, objectType=article, longId=139023, objectId=dbe61390237a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbe61390237a, replyNumber=0, likeNumber=79, createdTime=2018-10-05, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbe61390237a, moduleTitle=J Rheumatol：皮下阿巴西普治疗类风湿性关节炎的长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbe61390237a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720850, encodeId=184f1e20850c0, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究, objectType=article, longId=129880, objectId=62cb12988029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cb12988029, replyNumber=0, likeNumber=75, createdTime=2018-07-12, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cb12988029, moduleTitle=Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cb12988029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720825, encodeId=6a221e2082572, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Liver Int ：ombitasvir, Paritaprevir/+Dasabuvir+Ribavirin对基因1b型丙型肝炎肝硬化患者的疗效和安全性分析, objectType=article, longId=110983, objectId=fd4a11098334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd4a11098334, replyNumber=0, likeNumber=79, createdTime=2017-12-12, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd4a11098334, moduleTitle=Liver Int ：ombitasvir, Paritaprevir/+Dasabuvir+Ribavirin对基因1b型丙型肝炎肝硬化患者的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd4a11098334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720826, encodeId=30851e2082620, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究, objectType=article, longId=111056, objectId=508e111056bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508e111056bc, replyNumber=0, likeNumber=67, createdTime=2017-09-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508e111056bc, moduleTitle=JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508e111056bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720830, encodeId=7f091e20830bf, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet oncol：Dacomitinib用作携带EGFR突变的非小细胞肺癌的一线疗法的疗效和安全性。, objectType=article, longId=114247, objectId=305411424ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=305411424ece, replyNumber=0, likeNumber=58, createdTime=2018-02-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=305411424ece, moduleTitle=Lancet oncol：Dacomitinib用作携带EGFR突变的非小细胞肺癌的一线疗法的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=305411424ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720819, encodeId=b0ed1e20819e2, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Heart：皮下植入型心律转复除颤器治疗疗效和安全性评价！, objectType=article, longId=105021, objectId=61b9105021e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61b9105021e3, replyNumber=0, likeNumber=64, createdTime=2018-05-02, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61b9105021e3, moduleTitle=Heart：皮下植入型心律转复除颤器治疗疗效和安全性评价！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61b9105021e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720827, encodeId=ef921e2082785, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：Venetoclax联合硼替佐米和地塞米松对复发性/难治性多发性骨髓瘤的潜在疗效和安全性。, objectType=article, longId=111236, objectId=af39111236d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af39111236d6, replyNumber=0, likeNumber=48, createdTime=2018-06-10, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af39111236d6, moduleTitle=Blood：Venetoclax联合硼替佐米和地塞米松对复发性/难治性多发性骨髓瘤的潜在疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af39111236d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720843, encodeId=bd951e20843ae, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性, objectType=article, longId=125034, objectId=675212503410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=675212503410, replyNumber=0, likeNumber=59, createdTime=2018-02-24, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=675212503410, moduleTitle=J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=675212503410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720814, encodeId=185f1e2081405, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Thromb Haemostasis：VTE复发治疗和预防中采用利伐沙班与华法林的疗效和安全性比较?, objectType=article, longId=103278, objectId=75d61032e8de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d61032e8de, replyNumber=0, likeNumber=71, createdTime=2017-09-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d61032e8de, moduleTitle=Thromb Haemostasis：VTE复发治疗和预防中采用利伐沙班与华法林的疗效和安全性比较?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75d61032e8de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720828, encodeId=4d481e2082842, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JAMA Surg：口内镜甲状腺前庭切除术的疗效和安全性研究, objectType=article, longId=112273, objectId=503f1122e3b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=503f1122e3b3, replyNumber=0, likeNumber=62, createdTime=2017-11-01, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=503f1122e3b3, moduleTitle=JAMA Surg：口内镜甲状腺前庭切除术的疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=503f1122e3b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720855, encodeId=5f9b1e2085532, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, objectType=article, longId=132424, objectId=a7f51324240d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f51324240d, replyNumber=0, likeNumber=65, createdTime=2018-08-19, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f51324240d, moduleTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f51324240d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720811, encodeId=508e1e20811be, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较, objectType=article, longId=101283, objectId=bb5010128393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb5010128393, replyNumber=0, likeNumber=82, createdTime=2018-03-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb5010128393, moduleTitle=Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb5010128393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720823, encodeId=1fef1e208233e, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Diabetes Care：控制不佳的2型糖尿病患者采用双醋瑞因治疗的疗效和安全性分析！, objectType=article, longId=109286, objectId=7ad81092864a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ad81092864a, replyNumber=0, likeNumber=59, createdTime=2018-06-26, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ad81092864a, moduleTitle=Diabetes Care：控制不佳的2型糖尿病患者采用双醋瑞因治疗的疗效和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ad81092864a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720848, encodeId=f1cb1e20848a9, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JAHA：吗啡用于急性ST段抬高型心肌梗死的疗效和安全性分析！, objectType=article, longId=129639, objectId=9cc5129639f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cc5129639f9, replyNumber=0, likeNumber=42, createdTime=2018-07-27, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cc5129639f9, moduleTitle=JAHA：吗啡用于急性ST段抬高型心肌梗死的疗效和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cc5129639f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720856, encodeId=91401e20856da, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, objectType=article, longId=132551, objectId=bc0a132551d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0a132551d5, replyNumber=0, likeNumber=45, createdTime=2018-04-02, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0a132551d5, moduleTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0a132551d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720835, encodeId=da631e2083590, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, objectType=article, longId=118856, objectId=23071188567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23071188567a, replyNumber=0, likeNumber=102, createdTime=2017-11-26, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23071188567a, moduleTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23071188567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720837, encodeId=9be91e208372e, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Clin Diagn Res：单侧腰麻和连续腰麻-硬膜外联合麻醉用于下肢骨科手术的疗效和安全性的比较, objectType=article, longId=119853, objectId=893e119853c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=893e119853c0, replyNumber=0, likeNumber=70, createdTime=2018-05-14, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=893e119853c0, moduleTitle=J Clin Diagn Res：单侧腰麻和连续腰麻-硬膜外联合麻醉用于下肢骨科手术的疗效和安全性的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=893e119853c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720829, encodeId=09661e2082945, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet：多西他赛联合雷莫芦单抗治疗晚期或转移尿路上皮细胞癌的疗效和安全性。, objectType=article, longId=112798, objectId=531b112e9870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531b112e9870, replyNumber=0, likeNumber=56, createdTime=2018-05-08, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531b112e9870, moduleTitle=Lancet：多西他赛联合雷莫芦单抗治疗晚期或转移尿路上皮细胞癌的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531b112e9870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720834, encodeId=3b591e2083423, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Arthritis Rheumatol：阿塞西普治疗系统性红斑狼疮的疗效和安全性, objectType=article, longId=118052, objectId=dc5f11805255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5f11805255, replyNumber=0, likeNumber=99, createdTime=2018-04-24, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5f11805255, moduleTitle=Arthritis Rheumatol：阿塞西普治疗系统性红斑狼疮的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5f11805255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720842, encodeId=02e11e20842f8, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Clin Transl Allergy：屋尘螨皮下免疫治疗在老年过敏性鼻炎患者中的疗效和安全性证据, objectType=article, longId=124126, objectId=d329124126be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d329124126be, replyNumber=0, likeNumber=102, createdTime=2018-06-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d329124126be, moduleTitle=Clin Transl Allergy：屋尘螨皮下免疫治疗在老年过敏性鼻炎患者中的疗效和安全性证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d329124126be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效和安全性

2020-05-29

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Rheumatol：皮下阿巴西普治疗类风湿性关节炎的长期疗效和安全性

2018-10-05

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lung Cancer：纳武单抗治疗NSCLC的疗效和安全性：真实世界研究

2018-07-12

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Liver Int ：ombitasvir, Paritaprevir/+Dasabuvir+Ribavirin对基因1b型丙型肝炎肝硬化患者的疗效和安全性分析

2017-12-12

一叶知秋 (审核中...)

前往app查看评论内容

#疗效和安全性#

JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究

2017-09-07

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet oncol：Dacomitinib用作携带EGFR突变的非小细胞肺癌的一线疗法的疗效和安全性。

2018-02-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Heart：皮下植入型心律转复除颤器治疗疗效和安全性评价！

2018-05-02

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：Venetoclax联合硼替佐米和地塞米松对复发性/难治性多发性骨髓瘤的潜在疗效和安全性。

2018-06-10

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性

2018-02-24

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Thromb Haemostasis：VTE复发治疗和预防中采用利伐沙班与华法林的疗效和安全性比较?

2017-09-30

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JAMA Surg：口内镜甲状腺前庭切除术的疗效和安全性研究

2017-11-01

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性

2018-08-19

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较

2018-03-30

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Diabetes Care：控制不佳的2型糖尿病患者采用双醋瑞因治疗的疗效和安全性分析！

2018-06-26

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JAHA：吗啡用于急性ST段抬高型心肌梗死的疗效和安全性分析！

2018-07-27

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估

2018-04-02

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！

2017-11-26

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Clin Diagn Res：单侧腰麻和连续腰麻-硬膜外联合麻醉用于下肢骨科手术的疗效和安全性的比较

2018-05-14

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet：多西他赛联合雷莫芦单抗治疗晚期或转移尿路上皮细胞癌的疗效和安全性。

2018-05-08

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Arthritis Rheumatol：阿塞西普治疗系统性红斑狼疮的疗效和安全性

2018-04-24

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Clin Transl Allergy：屋尘螨皮下免疫治疗在老年过敏性鼻炎患者中的疗效和安全性证据

2018-06-30

科室
- - 订阅+
  - 更多科室
工具
服务